| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/14/1996 | EP0696585A1 Novel bisoxadiazolidine derivative |
| 02/14/1996 | EP0696583A1 Benzimidazolesulfonamide derivatives and pharmaceutical composition |
| 02/14/1996 | EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels |
| 02/14/1996 | EP0696577A1 Synthetic excitatory amino acids |
| 02/14/1996 | EP0696456A2 Combination of necrosis inducing substances with substances which are activated by necrosis for the selective treatment of tumours and or inflammatory diseases |
| 02/14/1996 | EP0696454A2 Pharmaceutical preparation for contraception/hormonsubstitution with biogenic estrogen components |
| 02/14/1996 | EP0696453A2 Pediatric lipid emulsion |
| 02/14/1996 | EP0696452A1 Nanoemulsion of the oil in water type, useful as an ophthalmic vehicle and process for the preparation thereof |
| 02/14/1996 | EP0696318A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 02/14/1996 | EP0696292A1 Spirostanyl glycosidal crystalline monohydrate |
| 02/14/1996 | EP0696291A1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments |
| 02/14/1996 | EP0696290A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
| 02/14/1996 | EP0696289A1 Benzo f]quinoxalindione derivatives, their preparation and their use in drugs |
| 02/14/1996 | EP0696288A1 Quinoxalindione derivatives, their preparation and their use in drugs |
| 02/14/1996 | EP0696287A1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
| 02/14/1996 | EP0696285A1 Water soluble derivatives of camptothecin and their use as antitumor agents |
| 02/14/1996 | EP0696284A1 Heterocyclic derivatives |
| 02/14/1996 | EP0696281A1 Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives |
| 02/14/1996 | EP0696277A1 Hiv protease inhibitors useful for the treatment of aids |
| 02/14/1996 | EP0696276A1 N-acyl substituted phenyl piperidines as bronchodilators and anti-inflammatory agents |
| 02/14/1996 | EP0696275A1 Vitamin d amide derivatives |
| 02/14/1996 | EP0696272A1 Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl-1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives |
| 02/14/1996 | EP0696271A1 Cyclooxygenase and 5-lipoxygenase inhibiting hydroxamic acid derivatives |
| 02/14/1996 | EP0696270A1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs |
| 02/14/1996 | EP0696208A1 Oral drug delivery compositions and methods |
| 02/14/1996 | EP0696205A1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 02/14/1996 | EP0696202A1 Pharmaceutical composition containing thymoctonan and azt |
| 02/14/1996 | EP0696201A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 02/14/1996 | EP0696200A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 02/14/1996 | EP0696196A1 Use of oral diazoxide for the treatment of disorders in glucose metabolism |
| 02/14/1996 | EP0696195A1 Use of sabeluzole in chronic neurodegenerative diseases |
| 02/14/1996 | EP0696194A1 Use of indole derivatives as 5ht1 antagonists |
| 02/14/1996 | EP0696190A1 Nasal aromatic releasing compositions |
| 02/14/1996 | CN1116849A Process for the manufacture of a tricyclic compound |
| 02/14/1996 | CN1116847A N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists |
| 02/14/1996 | CN1116824A Topical ketoconazole compositions |
| 02/14/1996 | CN1116823A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/14/1996 | CN1116822A Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| 02/14/1996 | CN1116629A Monomeric insulin analog formulations |
| 02/14/1996 | CN1116626A Glucopyranoside benzothiophens |
| 02/14/1996 | CN1116625A Method for preparing anti-asthmatic and antitussive medicine |
| 02/14/1996 | CN1116526A Medicament for therapeuttic and prophylactic treatment of diseases caused by smooth muscle cell hyperlastia |
| 02/14/1996 | CN1116525A 透皮吸收制剂 Transdermal preparations |
| 02/14/1996 | CN1116524A Formes galeniques a liberation prolongee du chlorhydrate d'alfuzosine |
| 02/14/1996 | CN1116521A Sustained release compositions and a method of preparing pharmaceutical compositions |
| 02/14/1996 | CN1030987C Process for indolo pyrrolo carbazole derivatives |
| 02/14/1996 | CN1030986C Process for pyrrolopyrazine |
| 02/14/1996 | CN1030964C Task-masking composition of bitter pharmaceutical agents |
| 02/13/1996 | US5491242 Treating diabetes mellitus |
| 02/13/1996 | US5491241 Bicyclic intermediates for excitatory amino acid receptor antagonists |
| 02/13/1996 | US5491237 Catalytic dehydroxylation, oxidation, enzymatic acylation, catalytic isomerization, cyclization, intramolecular heck reaction |
| 02/13/1996 | US5491236 (1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives |
| 02/13/1996 | US5491231 Hindered N-oxide esters of rapamycin |
| 02/13/1996 | US5491229 Rapamycin derivative |
| 02/13/1996 | US5491173 Estrogenic, antiestrogenic agents, antitumor agents |
| 02/13/1996 | US5491172 Acylcoenzyme a:cholesterol acyltransferase inhibitors |
| 02/13/1996 | US5491171 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
| 02/13/1996 | US5491169 Amino acid derivatives and their therapeutical applications |
| 02/13/1996 | US5491167 Inhibitors of cholesterol biosynthesis |
| 02/13/1996 | US5491166 Inhibitors of HIV protease useful for the treatment of AIDS |
| 02/13/1996 | US5491164 Inhibitors of farnesyl-protein transferase |
| 02/13/1996 | US5491163 (Thia)cycloalkyl[B]indoles |
| 02/13/1996 | US5491159 Inhibit oxidative modification of low density lipoproteins |
| 02/13/1996 | US5491158 Treating diseases of rheumatoid genesis |
| 02/13/1996 | US5491154 A premixes of nimodipine, citric acid, sodium bicarbonate, citrus flavor and organe granules; solubility |
| 02/13/1996 | US5491151 Administering to mammal, a cyanine dye for activation of macrophases in mammal |
| 02/13/1996 | US5491150 Supplementary therpeutic agents for the treatment of immunodeficiency syndrome |
| 02/13/1996 | US5491147 Tri-substituted phenyl derivatives and their use in pharmaceutical compositions and methods of treatment |
| 02/13/1996 | US5491142 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 02/13/1996 | US5491141 Enzyme inhibitors, hypertensive agents; treating diuretic, congestive heart failure, aldosteronism, renal diseases, glaucoma |
| 02/13/1996 | US5491140 Naphthyl tachykinin receptor antagonists to treat physiological conditions |
| 02/13/1996 | US5491138 Estradiol derivative alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting composition containing the conjugate or estradiol derivative |
| 02/13/1996 | US5491137 Treating estrogen deficiency |
| 02/13/1996 | US5491135 Compositions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals |
| 02/13/1996 | US5491132 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
| 02/13/1996 | US5490987 Tableting of colestipol hydrochloride |
| 02/13/1996 | US5490984 Injecting wound healing agents into defective area |
| 02/13/1996 | US5490498 Adding fluorocarbon along with breathing gas which oxygenates the fluorocarbon; treatment of respiratory distress syndrome |
| 02/13/1996 | CA2090422C Pharmaceutical composition of florfenicol |
| 02/13/1996 | CA2035841C Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture |
| 02/12/1996 | CA2155448A1 Inhibitors of farnesyl protein transferase |
| 02/12/1996 | CA2154977A1 Benzimidazolesulfonamide derivatives and pharmaceutical composition |
| 02/08/1996 | WO1996003515A2 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | WO1996003426A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 02/08/1996 | WO1996003422A1 4-azasteroids with side-chain fluoroketones |
| 02/08/1996 | WO1996003421A1 Neurologically active aminosteroids |
| 02/08/1996 | WO1996003420A1 3-carboxysteroids with a fluorinated side chain |
| 02/08/1996 | WO1996003419A1 Tetracyclic triterpenes |
| 02/08/1996 | WO1996003414A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 02/08/1996 | WO1996003411A1 D-mannose or xylitol esters and their use as drugs |
| 02/08/1996 | WO1996003407A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | WO1996003406A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | WO1996003405A1 Imidazopyridine-azolidinones |
| 02/08/1996 | WO1996003404A1 Acyl imidazopyridines |
| 02/08/1996 | WO1996003403A1 Benzyl-imidazopyridines |
| 02/08/1996 | WO1996003402A1 Halogenated imidazopyridines |
| 02/08/1996 | WO1996003401A2 Process for the production of aminoazobicycloalkanes from oximes |
| 02/08/1996 | WO1996003400A1 4-indole derivatives as serotonin agonists and antagonists |
| 02/08/1996 | WO1996003399A1 Dihydrobenzofuranes |
| 02/08/1996 | WO1996003398A1 Hemoregulatory compounds |